TransMedics Group (NASDAQ:TMDX) Receives Overweight Rating from Piper Sandler

Piper Sandler reiterated their overweight rating on shares of TransMedics Group (NASDAQ:TMDX – Free Report) in a research note released on Wednesday, Benzinga reports. Piper Sandler currently has a $120.00 price objective on the stock, up from their previous price objective of $95.00. A number of other brokerages also recently weighed in on TMDX. JPMorgan […]

Related Keywords

United States ,Waleedh Hassanein ,Piper Sandler ,Riverpark Advisors ,Transmedics Group Trading ,News Ratings For Transmedics Group Daily ,Cutler Group ,Morgan Stanley ,First Horizon Advisors Inc ,Institutional Investors Weigh In On Transmedics Group ,Analyst Recommendations For Transmedics Group ,Securities Exchange Commission ,Insider Transactions At Transmedics Group ,Associates Corp ,Venturi Wealth Management ,Transmedics Group Inc ,Jpmorgan Chase Co ,Transmedics Group Company Profile ,Transmedics Group ,Free Report ,Moderate Buy ,Medics Group ,Get Free Report ,Exchange Commission ,Wealth Management ,Horizon Advisors ,Park Advisors ,Organ Care System ,Transmedics Group Daily ,Nasdaq Tmdx ,Tmdx ,Medical ,Reiterated Rating ,